Diabetes Type 2
FDA Clears First Over-the-Counter Continuous Glucose Monitor for Children
As reported on CNET, parents and caregivers now have a new option to help monitor children’s blood sugar levels at home. The US Food and
Some Dialysis Humor, Part 1
FDA Issues Complete Response Letter for Rivoceranib–Camrelizumab Combination in Advanced Liver Cancer
ISTH 2026: Long-Term Phase 3 Data Support Denecimig as a Flexible Prophylactic Option for Hemophilia A
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
Renal Cell Carcinoma
FDA Approves Pembrolizumab–Belzutifan Combination for Adjuvant Treatment of High-Risk Clear Cell RCC
As reported on Pharmaceutical Technology, the US Food and Drug Administration (FDA) has approved a new adjuvant treatment option for adults with clear cell renal
Rare Disease
FDA’s New Framework Signals Turning Point for Rare Disease Therapies—But Major Barriers Remain
As reported on MedCity News, the U.S. Food and Drug Administration (FDA) has introduced a new regulatory pathway that could reshape how treatments are developed
HIV/AIDS
FDA Reviews Gilead’s Once-Weekly Oral Lenacapavir for HIV Prevention
As reported on Business Wire, Gilead Sciences has announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application for
Lynch syndrome
Hereditary Cancer Risk Is Harder to Detect When Family History Crosses Borders
I grew up believing health was something you could control if you were disciplined enough. In my Chinese immigrant family, my father talked constantly about
Diabetes Type 1
FDA Grants Accelerated Approval to Teplizumab for Newly Diagnosed Pediatric Type 1 Diabetes
As shared in a recent press release, the U.S. Food and Drug Administration (FDA) has granted accelerated approval to teplizumab (Tzield) for a new pediatric
Idiopathic Hypersomnia
Alkermes’ Alixorexton Gains Orphan Drug Status in the US and EU
As reported by Pharmaceutical Technology, Alkermes has announced that its investigational therapy alixorexton has received orphan drug designation from both US and European regulators, marking
IgA Nephropathy
AstraZeneca’s Ravulizumab Receives FDA Priority Review for IgA Nephropathy
As reported on PharmaBiz, AstraZeneca has announced that the US Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA)
Rare Disease
FDA Signals Shift Toward Bayesian Methods in Clinical Trials
As reported on MedCity News, the U.S. Food and Drug Administration (FDA) has issued draft guidance encouraging the thoughtful use of Bayesian statistical approaches in
Thyroid eye disease
Glycemic Monitoring Recommended for All Patients Receiving Teprotumumab in Thyroid Eye Disease
Emerging evidence, as reported by the American Academy of Ophthalmology, suggests that glycemic surveillance should be considered for all patients undergoing teprotumumab therapy for thyroid
Rare Disease
Aortic Valvotomy, A Widening of Heart Valves
When Seth Wharton was only one month old, doctors repaired his narrow heart valve. Then, five years later, he was referred to UAB Cardiovascular Institute
Dravet Syndrome
An Update from the Dravet Syndrome Foundation
Madrid, June 5th, 2026 The Dravet Syndrome Foundation received the Merck Innovation Talent Award for a scientific publication regarding a tool that assesses neuropsychiatric issues
Neurotrophic Keratopathy
TearSolutions Advances Lacripep® for Neurotrophic Keratitis with FDA Designations and Phase 2 Trial Launch
As reported on Business Wire, TearSolutions, a clinical-stage biotechnology company focused on ophthalmic therapies, has announced key regulatory and clinical progress for its investigational drug
Fabry Disease
Fabry International Network’s Young Adult Guidebook
Website: https://fabrynetwork.org/youngadults Instagram Young Adults: @fabryyoungadults Instagram FIN: @fabryintnetwork 11 June 2026 – FIN launches international Young Adults Guidebook created by and for young adults
Parkinson's Disease
Finding Balance: David and Charice’s Journey with Parkinson’s Disease
When David Williams noticed a slight tremor in his right hand, he convinced himself it was something manageable, perhaps a compressed nerve that would eventually
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
Some of the hardest work people living with chronic illness do is the work no one ever sees.
It's the constant problem-solving, adapting, planning, and making difficult decisions throughout the day- often while trying to maintain a sense of normalcy. These invisible responsibilities require time, energy, and resilience, yet they're rarely recognized.
Which invisible job do you think deserves more recognition?
#patientadvocacy #chronicilness #PatientWorthy
Gastric (stomach) cancer and gastroesophageal junction (GEJ) cancer are closely related, but they develop in different parts of the digestive system. Learning the differences, understanding who may be at higher risk, and recognizing the importance of early detection can help raise awareness and encourage conversations with healthcare providers.
Swipe through to learn more about these two types of cancer and if you'd like to share your story, click here: ow.ly/IAJm50Znsj5 or click the link in our bio.
#GastricCancer #stomachcancer #gejcancer #EsophagealCancer #cancerawareness #shareyourstory #PatientWorthy
Metastatic Breast Cancer ? Take the survey! METAvivor Research and Support Inc.
